[Skip to Content]
[Skip to Content Landing]

Drug Spending, Biologics, and Biosimilars: Health Care Trends

Learning Objectives
1. Identify current trends in drug spending, biologics, biosimilars, cancer drugs and drug shortages
2. Define causes of, and efforts taken, to mitigate the rising costs of prescription drugs and drug shortages
3. Explain predicted impacts of drug spending and drug shortage trends for patients, physicians, payers and policymakers
0.75 Credit CME

As part of the Health Care Trends series, in this course you will learn about trends on current and projected prescription drug spending, Medicare Part D prescription drug coverage, projected drug spending, public opinion on drug costs and proposed controls, biologics and biosimilars, cancer drugs, and drug shortages. The course also posits projected impacts of these trends.

Please finish the activity before taking the quiz

Sign in to take quiz and track your certificates

The AMA Ed Hub™ is a unified education portal that provides a personalized experience for physicians and their care teams to keep current, increase their professional satisfaction, claim continuing education credits and continuously improve the care they provide–leading to real world outcomes of better healthcare and better health for their patients. Learn more

Module not playing? Click here

Activity Information

Copyright Statement:

© 2018 American Medical Association. All rights reserved.

In producing this publication, the AMA Council on Long Range Planning and Development has consulted and cited sources believed to be knowledgeable. However, the AMA does not warrant that the information is in every respect accurate and/or complete. The AMA assumes no responsibility for use of the information contained in this publication. The AMA shall not be responsible for, and expressly disclaims liability for, damages of any kind arising out of the use of, reference to, or reliance on, the content of this publication.

This publication is for informational purposes only. The AMA does not provide medical, legal, financial, or other professional advice, and readers are encouraged to consult a professional adviser for such advice.

Credit Designation Statement: The American Medical Association designates this enduring material activity for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.

Renewal Date: June 18, 2020

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

0.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;

0.75 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;

0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and

0.75 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program;

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.


Name Your Search

Save Search

Lookup An Activity



My Saved Searches

You currently have no searches saved.